Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
29.77
-0.04 (-0.13%)
At close: Feb 27, 2026
SHA:603207 Market Cap
SHA:603207 has a market cap or net worth of 4.79 billion as of February 27, 2026. Its market cap has increased by 11.61% in one year.
Market Cap
4.79B
Enterprise Value
4.05B
Revenue
504.59M
Ranking
n/a
PE Ratio
22.42
Stock Price
29.77
Market Cap Chart
Since August 26, 2024, SHA:603207's market cap has decreased from 5.33B to 4.79B, a decrease of -10.14%. That is a compound annual growth rate of -6.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 4.79B | 4.19% |
| Dec 31, 2025 | 4.60B | 2.24% |
| Dec 31, 2024 | 4.49B | -15.65% |
| Aug 26, 2024 | 5.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Newland Pharmaceutical | 5.01B |
| Shanghai Jiaoda Onlly Co.,Ltd | 4.88B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 4.87B |
| Tibet Weixinkang Medicine | 4.85B |
| Ningbo Menovo Pharmaceutical | 4.73B |
| Jinling Pharmaceutical Company | 4.71B |
| Jinhe Biotechnology CO., LTD. | 4.69B |
| LanZhou Foci Pharmaceutical | 4.65B |